Delivery Order SPE2DB22D1103-SPE2DB25FTJN6

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $17,880.62 and a period of performance ending on March 26, 2025. The contract is for the procurement of TREMFYA 100 MG/ML SYRINGE/ML, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product. The ceiling value of this order is $11,961.19, with an ultimate completion date of August 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $23,618.24 and a period of performance through May 19, 2025. The contract is a firm fixed-price type and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,266.87, is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a specialty medication, with a ceiling value of $20,501.98 and a period of performance through July 3, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $55,988.24 and runs through April 9, 2025. It is a firm-fixed-price contract for the supply of TREMFYA 100 MG/ML syringes. The contract is not designated as a set-aside and represents open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TREMFYA 100 MG/ML SYRINGEML. The order, valued at $73,161.62, has a firm fixed price and an ultimate completion date of August 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive range of medical commodities to...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $14,549.75, is for the provision of TREMFYA 100 MG/ML SYRINGEML, a specialty medication. The award is not designated as a set-aside contract. It is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,978.97, is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of TREMFYA 100 MG/ML SYRINGE medical supplies, with a ceiling value of $49,771.66 and a performance period through June 5, 2025. The contract is designated as a firm fixed-price, non-set-aside delivery order. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTJN6
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $10,348.59 and a period of performance through April 4, 2025.

The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC serves as a primary contracting vehicle for the company to deliver critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, across multiple therapeutic domains.

Generated 7/3/25, 2:42 PM